Unichem Pharmaceuticals (USA) Inc. is recalling 96,876 bottles of Divalproex Sodium Delayed Release Tablets USP (500 mg), a medication used to treat seizures and bipolar disorder. The recall was initiated because metronidazole powder, an antibiotic, was found inside a bottle of the medication. Consumers should contact their healthcare provider or pharmacist immediately to discuss their treatment and how to obtain a safe replacement.
The presence of metronidazole powder in a bottle of Divalproex Sodium poses a risk of cross-contamination. Patients may unintentionally ingest an unintended medication, which could lead to adverse drug reactions or interfere with the effectiveness of their prescribed seizure or mood disorder treatment.
Healthcare consultation and pharmacy refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.